Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | XVir-N-31 |
Synonyms | |
Therapy Description |
XVir-N-31 is an oncolytic adenovirus that preferentially replicates in tumor cells expressing YBX1 (YB-1), which may induce tumor cell lysis and increase tumor growth inhibition (PMID: 19363467, PMID: 36892582). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
XVir-N-31 | Ad-Delo3-RGD | XVir-N-31 is an oncolytic adenovirus that preferentially replicates in tumor cells expressing YBX1 (YB-1), which may induce tumor cell lysis and increase tumor growth inhibition (PMID: 19363467, PMID: 36892582). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|